Lord, Abbett & Co’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
CIP
WHG
Lord, Abbett & Co's CNMD Position: Q2 2024 in Review
Lord, Abbett & Co sold out of CONMED (CNMD) in Q2 2024, closing a stake of 147,620 shares — an estimated $11.8M sold.
Lord, Abbett & Co first reported a position in CNMD in Q2 2016 and held it in 18 quarters. The position peaked at $37.4M in Q1 2022. 290 funds tracked by Wall St. Rank hold CNMD as of Q2 2024.
- Lord, Abbett & Co reported no remaining CONMED position as of Q2 2024 after selling out during the quarter.
- Lord, Abbett & Co sold 147,620 CONMED shares in Q2 2024, an estimated $11.8M.
- Lord, Abbett & Co first reported a position in CONMED in Q2 2016 and held it in 18 quarters.
- Lord, Abbett & Co's CONMED position peaked at $37.4M in Q1 2022.
- 290 funds tracked by Wall St. Rank held CONMED as of Q2 2024.
Based on Lord, Abbett & Co's 13F filing for Q2 2024, filed 14 Aug 2024.